Blue chip investors back new MedTech investment company
Segulah Medical Acceleration, SMA, is a newly formed company specializing in medical technology investments, with a focus on Sweden, Scandinavia and Western Europe. The company is financed by leading institutions and prominent private investors, whose initial commitments amount to approximately SEK 1.2 billion.The initiator behind Segulah Medical Acceleration is Gabriel Urwitz, founder of Nordic private equity fund group Segulah. SMA is an investment company, whose objective is to help young, innovative medtech companies in Europe accelerate growth and to reach commercially sustainable